 |
|
| Blog results | Results 1 - 10 of about 441 for vancocin antibiotic. (0.27 seconds) |
| Sorted by relevance Sort by date |
| 7 hours ago by John McCalister However, according to Zacks Equity Research, VIBATIV will face tough competition from other antibiotic drugs, such as ViroPharma's Vancocin and Johnson & Johnson (NYSE:JNJ) ceftobiprole. The market analyst also predicted “an initial ... FavStocks - http://www.favstocks.com/ |
| 28 Aug 2009 by David Phillips The relative efficacy of Optimer Pharma's investigational antibiotic, fidaxomicin, compared to standard-of-care vancomycin (marketed as Vancocin. Pharma RSS Feed - http://industry.bnet.com/pharma/ |
| 12 Aug 2009 by David J. Phillips The relative efficacy of Optimer Pharma's (OPTR-$13.49) investigational antibiotic, fidaxomicin, compared to standard-of-care vancomycin (marketed as Vancocin by drugmaker ViroPharma), for the treatment of the hospital-acquired ... 10Q Detective - http://10qdetective.blogspot.com/ [ More results from 10Q Detective ] |
| 12 Nov 2009 by Maureen Martino In addition, patients treated with fidaxomicin in the first Phase 3 trial experienced a reduction in CDI recurrence compared to Vancocin (p=0.004) and had a higher global cure (cure with no recurrence within four weeks) compared to ... Press Releases - http://www.fiercebiotech.com/press-releases |
| 21 Nov 2009 by asghar Antibiotic agents. Empiric antimicrobial therapy in bacterial tracheitis must be comprehensive and should cover all likely pathogens in the context of the clinical setting. Oxacillin (Bactocill, Prostaphlin) ... Vancomycin (Vancocin) May be used in severe cases or in cases with a history of allergies instead of oxacillin for coverage of gram-positive organisms (eg, S aureus, S pyogenes). Dosing Adult 15 mg/kg/dose IV q8h; not to exceed 2 g/d. Pediatric ... usmle preparation - http://ticpuny.blogspot.com/ |
| 3 Aug 2009 by Rxmedyn According to FDA's briefing documents, Vancocin – which is indicated to treat staphylococcal enterocolitis and antibiotic-based associated pseudomembranous colitis caused by Clostridium difficile – is highly soluble over a wide range of ... Medical Dynamics - http://www.rxmedyn.com/blog/ |
| 4 Nov 2009 by admin For years, the potent antibiotic vancomycin (Vancocin) was a reliable last defense against certain severe infections, notably those caused by staphylococcus bacteria. But in recent years, some superbugs have become able to resist ... Suzhou Time-Chem Technologies Co.,Ltd - http://www.timepharm.com/blog/ |
| 6 Aug 2009 by pharmafeed an fda advisory committee voted unanimously in favour of agency draft guidelines for developing generic versions of viropharma's antibiotic vancocin (vancomycin) that do not require comparative studies in humans to establish ... pharmafeed - http://www.pharmafeed.com/ |
| 9 Oct 2009 by vitalstocks There are many players targeting bacterial infections market – ViroPharma's (VPHM) Vancocin, Pfizer's Zyvox and Wyeth's (WYE) Tygacil. The drug will also have to fight off competition from pipeline candidates such as Johnson & Johnson's ... Stock Blog Hub - http://www.stockbloghub.com/ [ More results from Stock Blog Hub ] |
| 5 Aug 2009 ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
